19q13.11 microdeletion syndrome

19q13.11 microdeletion syndrome (also known as 19q13.11 deletion syndrome) is a rare chromosomal disorder caused by a small deletion (microdeletion) on the long arm of chromosome 19 at band q13.11. This condition is characterized by intellectual disability, speech and language delay, and distinctive facial features. The deletion typically encompasses several genes, and the loss of these genes disrupts normal development, particularly affecting the central nervous system. Key clinical features include moderate to severe intellectual disability, significant speech delay or absence of speech, feeding difficulties in infancy, and behavioral abnormalities. Affected individuals may also present with growth retardation, microcephaly, seizures or epilepsy, and various dysmorphic facial features such as a thin upper lip, long philtrum, and prominent ears. Some patients exhibit ectodermal abnormalities including thin or sparse hair and cutis aplasia (areas of absent skin, particularly on the scalp). Limb anomalies and urogenital malformations have also been reported in some cases. There is currently no cure or specific targeted therapy for 19q13.11 microdeletion syndrome. Management is supportive and symptomatic, focusing on early intervention programs including speech therapy, occupational therapy, and physical therapy. Seizures are managed with standard antiepileptic medications. Feeding difficulties may require specialized nutritional support. Regular developmental assessments and multidisciplinary follow-up are recommended to address the various medical and developmental needs of affected individuals. The syndrome is typically diagnosed through chromosomal microarray analysis (array CGH).

Common questions about 19q13.11 microdeletion syndrome